Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cognitive Neuropsychiatry

• Publication date

  2018-02-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/13546805.2018.1440201PMID 29447074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of acute inflammation on cognitive functioning and emotional processing in humans: A systematic review of experimental studies.

  2017cited by this paper
• In Sickness and in Health: The Co-Regulation of Inflammation and Social Behavior

  2017cited by this paper
• Immune markers of social cognitive bias in schizophrenia.

  2017cited by this paper
• Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-α, IFN-γ, ΤNF-β, IL-4 deviation.

  2017cited by this paper
• Evidence for Hypothalamus-Pituitary-Adrenal Axis and Immune Alterations at Prodrome of Psychosis in Males

  2017cited by this paper
• Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males.

  2016cited by this paper
• Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

  2016cited by this paper
• Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.

  2016cited by this paper
• IGF-I: A Key Growth Factor that Regulates Neurogenesis and Synaptogenesis from Embryonic to Adult Stages of the Brain

  2016cited by this paper
• Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback.

  2016cited by this paper
• Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study

  2016cited by this paper
• A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

  2015cited by this paper
• Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis

  2015cited by this paper
• Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects

  2015cited by this paper
• How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis.

  2015cited by this paper
• Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.

  2015cited by this paper
• Role of cortisol in patients at risk for psychosis mental state and psychopathological correlates: A systematic review

  2015cited by this paper
• Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.

  2015cited by this paper
• The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

  2015cited by this paper
• Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors

  2014cited by this paper
• Emotional perception and theory of mind in first episode psychosis: the role of obsessive-compulsive symptomatology.

  2014cited by this paper
• Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

  2014cited by this paper
• Facial emotion identification in early-onset and first-episode psychosis: a systematic review with meta-analysis.

  2014cited by this paper
• The Role of Cortisol in First Episode of Psychosis: A Systematic Review

  2014cited by this paper
• The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.

  2014cited by this paper
• General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.

  2013cited by this paper
• Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence.

  2013cited by this paper
• Emotion recognition impairment is present early and is stable throughout the course of schizophrenia.

  2013cited by this paper
• Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis.

  2013cited by this paper
• Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk

  2013cited by this paper
• Affect recognition in people at clinical high risk of psychosis.

  2012cited by this paper
• Inflammation selectively enhances amygdala activity to socially threatening images

  2012cited by this paper
• Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.

  2012cited by this paper
• Social cognition in schizophrenia, Part 1: performance across phase of illness.

  2012cited by this paper
• Mentalizing in first-episode psychosis.

  2012cited by this paper
• Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients.

  2012cited by this paper
• Metacognition and social cognition in schizophrenia: stability and relationship to concurrent and prospective symptom assessments.

  2012cited by this paper
• Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.

  2012cited by this paper
• Insights into theory of mind in schizophrenia: the impact of cognitive impairment.

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Immune and neuroimmune alterations in mood disorders and schizophrenia.

  2011cited by this paper
• Metacognition in schizophrenia: correlates and stability of deficits in theory of mind and self-reflectivity.

  2011cited by this paper
• The Concept

  2010cited by this paper
• Immune System and Schizophrenia.

  2010cited by this paper
• Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders.

  2010cited by this paper
• The lifetime trajectory of schizophrenia and the concept of neurodevelopment

  2010cited by this paper
• Facial emotion perception in schizophrenia: a meta-analytic review.

  2010cited by this paper
• Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan.

  2009cited by this paper
• Theory of mind impairment in schizophrenia: meta-analysis.

  2009cited by this paper
• Facial affect recognition in individuals at clinical high risk for psychosis

  2008cited by this paper
• Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities.

  2008cited by this paper
• Studying Social Cognition in Patients with Schizophrenia and Patients with Frontotemporal Dementia: Theory of Mind and the Perception of Sarcasm

  2008cited by this paper
• The effect of antipsychotic treatment on Theory of Mind

  2007cited by this paper
• Theory of mind in schizophrenia: meta-analysis.

  2007cited by this paper
• CNS-Derived Interleukin-4 Is Essential for the Regulation of Autoimmune Inflammation and Induces a State of Alternative Activation in Microglial Cells

  2007cited by this paper
• Theory of mind and its relation to schizotypy

  2006cited by this paper
• Social cognition: a multi level analysis.

  2006cited by this paper
• Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness

  2005cited by this paper
• Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States

  2005cited by this paper
• TASIT: A New Clinical Tool for Assessing Social Perception After Traumatic Brain Injury

  2003cited by this paper
• [Evaluation of standardized training for the "Positive and Negative Syndrome Scale" (PANSS)].

  2000cited by this paper
• Inhibition of Th1 Immune Response by Glucocorticoids: Dexamethasone Selectively Inhibits IL-12-Induced Stat4 Phosphorylation in T Lymphocytes1

  2000cited by this paper
• IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood.

  1998cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety‐ and Depressive‐Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors

  2026cites this paper
• Cortisol in schizophrenia spectrum disorders: A comprehensive meta-analysis.

  2025cites this paper
• Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation

  2025cites this paper
• Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis.

  2025cites this paper
• Relationships Between Immune‐Inflammatory Features and Social Cognitive Impairments in Patients With Schizophrenia Spectrum Disorders: A Systematic Review

  2025influential citation
• Mentalizing impairments and hypermentalizing bias in individuals with first-episode schizophrenia-spectrum disorder and at-risk mental state: the differential roles of neurocognition and social anxiety

  2024cites this paper
• Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?

  2024cites this paper
• Facial emotion perception in individuals with clinical high risk for psychosis compared with healthy controls, first-episode psychosis, and in predicting psychosis transition: A systematic review and meta-analysis.

  2024cites this paper
• Variations in inflammatory regulators in male patients with chronic schizophrenia associated with psychopathology and cognitive deficits

  2024cites this paper
• Cortisol and cytokines in schizophrenia: A scoping review

  2023influential citation
• Social interaction, psychotic disorders and inflammation: A triangle of interest.

  2022cites this paper
• Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden.

  2022cites this paper
• Meta‐analysis of peripheral insulin‐like growth factor 1 levels in schizophrenia

  2022influential citation
• Rethinking Immunity and Cognition in Clinical High Risk for Psychosis.

  2022cites this paper
• Relationships among inflammation, social cognition, and social functioning in schizophrenia.

  2021cites this paper
• The impact of inflammation on neurocognition and risk for psychosis: a critical review

  2019cites this paper